Gaithersburg, MD, United States of America

Maxcyte Inc.


USPTO Granted Patents = 39



Trademarks = 20

Forward Citations = 980

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal James William Luther (20 out of 29 patents)

silverMedal Bertold Engler (20 out of 20 patents)

bronzeMedal Thomas Alan Peach (20 out of 20 patents)

4.  Andrea Besana (20 out of 28 patents)

5.  Nicholas Chopas (12 out of 12 patents)

6.  Linhong Li (11 out of 11 patents)

7.  Frank Modica (11 out of 11 patents)

8.  Madhusudan V Peshwa (7 out of 7 patents)

9.  Sergey Dzekunov (6 out of 6 patents)

10.  John W Holaday (4 out of 14 patents)

11.  Vininder Singh (4 out of 4 patents)

12.  Linda Liu (3 out of 17 patents)

13.  Hyung J Lee (3 out of 5 patents)

14.  Peter H Meserol (3 out of 3 patents)

15.  Weili Wang (1 out of 1 patent)


Core Competencies:
Electroporation Device
Genomic DNA Modification
Therapeutic Compositions
Processing Assembly
Electroporation Gasket
Regulated Flow Chamber
Biological Samples
Crystalline Metal Nitride
Computerized Electroporation
Electroporation Chamber
Flow Electroporation
Transfected Cells

39 patents:

Maxcyte Inc., based in Gaithersburg, Maryland, specializes in cell engineering and the development of innovative cell-based therapies. The company focuses on providing advanced technology platforms that facilitate the discovery and development of biologics, including therapeutic proteins and cell therapies. Maxcyte's proprietary flow electroporation technology enables efficient delivery of nucleic acids into cells, supporting research and development in various fields such as oncology, immunology, and regenerative medicine.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

39 Patents

#11 in Gaithersburg, MD

#104 in Maryland

#8,810 in US

#17,413 in the World

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America
Forward Citations = 980

21 inventors:

Please report any incorrect information to [email protected]
Loading…